[HTML][HTML] Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment

FH Du, EA Mills, Y Mao-Draayer - Autoimmunity Highlights, 2017 - Springer
The clinical success of anti-CD20 monoclonal antibody (mAb)-mediated B cell depletion
therapy has contributed to the understanding of B cells as major players in several …

Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment.

FH Du, EA Mills, Y Mao-Draayer - Auto-Immunity Highlights, 2017 - europepmc.org
The clinical success of anti-CD20 monoclonal antibody (mAb)-mediated B cell depletion
therapy has contributed to the understanding of B cells as major players in several …

[引用][C] Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment

FH Du, EA Mills, Y Mao-Draayer - Autoimmunity Highlights, 2017 - cir.nii.ac.jp
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment

FH Du, EA Mills, Y Mao-Draayer - 2017 - deepblue.lib.umich.edu
The clinical success of anti-CD20 monoclonal antibody (mAb)-mediated B cell depletion
therapy has contributed to the understanding of B cells as major players in several …

Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment

FH Du, EA Mills, Y Mao-Draayer - Autoimmunity Highlights, 2017 - search.proquest.com
The clinical success of anti-CD20 monoclonal antibody (mAb)-mediated B cell depletion
therapy has contributed to the understanding of B cells as major players in several …

[HTML][HTML] Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment

FH Du, EA Mills, Y Mao-Draayer - Auto-Immunity Highlights, 2017 - ncbi.nlm.nih.gov
The clinical success of anti-CD20 monoclonal antibody (mAb)-mediated B cell depletion
therapy has contributed to the understanding of B cells as major players in several …

[HTML][HTML] Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment

FH Du, EA Mills, Y Mao-Draayer - Autoimmunity …, 2017 - autoimmunhighlights.biomedcentral …
The clinical success of anti-CD20 monoclonal antibody (mAb)-mediated B cell depletion
therapy has contributed to the understanding of B cells as major players in several …

Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment

FH Du, EA Mills, Y Mao-Draayer - Autoimmunity Highlights, 2017 - infona.pl
The clinical success of anti-CD20 monoclonal antibody (mAb)-mediated B cell depletion
therapy has contributed to the understanding of B cells as major players in several …

Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment

FH Du, EA Mills, Y Mao-Draayer - Auto-immunity …, 2017 - pubmed.ncbi.nlm.nih.gov
The clinical success of anti-CD20 monoclonal antibody (mAb)-mediated B cell depletion
therapy has contributed to the understanding of B cells as major players in several …

[PDF][PDF] Next‑generation anti‑CD20 monoclonal antibodies in autoimmune disease treatment

FH Du, EA Mills, Y Mao‑Draayer - 2017 - autoimmunhighlights.biomedcentral …
The clinical success of anti-CD20 monoclonal antibody (mAb)-mediated B cell depletion
therapy has contributed to the understanding of B cells as major players in several …